Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2016

May 31, 2016

33431_dirs_2016-05-31_58a1a592-a133-490e-9fc8-c45859af5181.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-05-26

Reporting Person: GOLDBY STEVEN D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-28 Common Stock M 3475 $11.46 Acquired 31191 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-28 Restricted Stock Unit $ M 3475 Disposed 2016-05-28 Common Stock (3475) Direct
2016-05-26 Right to Buy Restricted Stock Unit (RSU) $ M 5222 Acquired Common Stock (5222) Direct

Footnotes

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: The restricted stock units were granted on May 28, 2015.

F3: The restricted stock units vested on May 28, 2016.

F4: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.